Remove Hormones Remove Life Science Remove Medicine Remove Radiology
article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

Re-imagining Radiology. Tackling this challenge with advanced technologies and products, radiology is a key enabler to transform healthcare, expanding personalized medicine and improving outcomes for patients. In particular, AI bears vast potential for advancing radiology.

article thumbnail

Bayer expands global clinical program for darolutamide in prostate cancer

The Pharma Data

The new Phase III clinical study, ARASTEP, will investigate the efficacy of darolutamide plus androgen deprivation therapy (ADT) versus ADT alone in hormone-sensitive prostate cancer, in patients with high-risk biochemical recurrence (BCR) who have no evidence of metastatic disease by conventional imaging and a positive PSMA PET/CT at baseline.